다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

CVGR

Covalent (CVGR)

Covalent

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CVGR

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2006/10/31	01:34	Business Wire	Covalent Group Changes Name to Encorium Group, Inc.	NASDAQ:CVGR	Covalent
2006/10/21	05:08	Business Wire	Covalent Group, Inc. Announces Results of Shareholder Vote	NASDAQ:CVGR	Covalent
2006/10/19	21:01	Business Wire	Covalent Signs $8.2 Million in Contracts For Multinational Studies to Treat Influenza	NASDAQ:CVGR	Covalent
2006/08/09	05:36	Business Wire	Covalent Reports 2006 Second Quarter Financial Results; Company to Hold Conference Call at 9:00 AM on Wednesday, August 9, 2006	NASDAQ:CVGR	Covalent
2006/08/07	21:24	Business Wire	Covalent Group, Inc. Announces $1.7 Million Contract For Phase 2 Clinical Trial in Atherosclerosis	NASDAQ:CVGR	Covalent
2006/08/02	23:14	Business Wire	Covalent Group, Inc. Schedules Second Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
2006/07/14	01:00	Business Wire	Covalent Group, Inc. Signs Contracts Totaling $1.5 Million for Clinical Studies Offering Advanced Therapeutic Approaches to Pat	NASDAQ:CVGR	Covalent
2006/07/07	03:15	Business Wire	Covalent Group Amends Business Combination Agreement with Remedium Oy	NASDAQ:CVGR	Covalent
2006/06/28	21:27	Business Wire	Covalent Group, Inc. Announces $2.1 Million of New Business Contracts; Reiterates Second Quarter Guidance	NASDAQ:CVGR	Covalent
2006/05/16	06:22	Business Wire	Covalent Reports 2006 First Quarter Financial Results and Summary Balance Sheet Data; Company to Hold Conference Call at 9:00 A	NASDAQ:CVGR	Covalent
2006/05/08	21:12	Business Wire	Covalent Group, Inc. Schedules First Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
2006/04/20	21:07	Business Wire	Covalent Group, Inc. Signs $1 Million Contract To Conduct Phase 1 Study of Drug to Prevent/Treat Infectious Disease	NASDAQ:CVGR	Covalent
2006/03/30	22:00	Business Wire	Covalent Group, Inc. Announces Additional New Business Contracts	NASDAQ:CVGR	Covalent
2006/03/22	07:15	Business Wire	Covalent Group, Inc. Announces $2.1 Million Contract To Conduct Patient Disease Registry In Hospitalized Subjects With Hyponatr	NASDAQ:CVGR	Covalent
2006/03/22	07:14	Business Wire	Covalent Group, Inc. Signs $1.3 Million in Consulting and Medical Writing Contracts to Support New Drug Applications (NDA) for	NASDAQ:CVGR	Covalent
2006/03/22	07:12	Business Wire	Covalent Reports 2005 Fourth Quarter and Year End Financial Results and Summary Balance Sheet Data; Company to Hold Conference	NASDAQ:CVGR	Covalent
2006/03/16	21:57	Business Wire	Covalent Group, Inc. Schedules Fourth Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
2006/03/03	22:12	Business Wire	Covalent Group, Inc. Enters into Combination Agreement with Remedium Oy; Conference Call Scheduled for 11:00 AM ET Today	NASDAQ:CVGR	Covalent
2006/02/08	23:31	Business Wire	Covalent Group, Inc. and Sudler & Hennessey Announce Strategic Partnership to Design and Conduct Global Patient Disease Registri	NASDAQ:CVGR	Covalent
2006/02/02	22:01	Business Wire	Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Dise	NASDAQ:CVGR	Covalent
2006/02/01	02:00	Business Wire	Covalent Group, Inc. Retains The Equity Group to Provide Investor Relations Services	NASDAQ:CVGR	Covalent
2006/01/24	22:00	PR Newswire (US)	Covalent Group, Inc. Announces Multiple New Business Contracts with an Aggregate Value of $1.0 Million	NASDAQ:CVGR	Covalent
2006/01/18	22:00	PR Newswire (US)	Covalent Group, Inc. Signs Contract for $2.3 Million to Conduct a Multinational Phase 2 Clinical Trial Involving a New Antithrom	NASDAQ:CVGR	Covalent
2005/12/08	21:00	PR Newswire (US)	Covalent Group, Inc. Signs Letter-of-Intent to Conduct $2.2 Million Multinational Phase 2 Clinical Trial in Cardiovascular Disea	NASDAQ:CVGR	Covalent
2005/12/05	21:01	PR Newswire (US)	Covalent Group, Inc. and Emergent BioSolutions Sign Contract to Develop Immune Globulins for Treatment Exposure of Anthrax Infec	NASDAQ:CVGR	Covalent
2005/11/18	23:30	PR Newswire (US)	CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial	NASDAQ:CVGR	Covalent
2005/11/12	00:20	PR Newswire (US)	/C O R R E C T I O N -- Covalent Group, Inc. /	NASDAQ:CVGR	Covalent
2005/11/11	07:01	PR Newswire (US)	Covalent Reports Results for Third Quarter 2005	NASDAQ:CVGR	Covalent
2005/11/07	22:03	PR Newswire (US)	Covalent Group, Inc. to Report Third Quarter 2005 Results on Thursday, November 10	NASDAQ:CVGR	Covalent
2005/10/06	22:01	PR Newswire (US)	Covalent Group, Inc. Announces $5.3 Million Contract to Provide Additional Services for a Global Phase 3 Trial in Hypertension	NASDAQ:CVGR	Covalent

검색 관련기사 보기:NASDAQ:CVGR

1 2 3 다음 >>

Triumph Financial

Wt Physica Gold

Strategic International ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관